Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes

NCT02686281 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Business reason

Conditions

Healthy

Interventions

DRUG: GMC-252-L-Lysine
OTHER: Placebo

Sponsor

Genmedica Therapeutics S.L.

Collaborators

[object Object]